Profund Advisors LLC Biogen Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 28,531 shares of BIIB stock, worth $4.25 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

28,531

Previous 26,921 5.98%

Holding current value

$4.25 Million

Previous $6.24 Million 11.38%

% of portfolio

0.21%

Previous 0.24%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $304,402 - $381,248	1,610 Added 5.98%	28,531 $5.53 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $1.5 Million - $1.86 Million	7,850 Added 41.16%	26,921 $6.24 Million
Q1 2024 May 08, 2024	SELL	$212.02 - $267.71 $114,702 - $144,831	-541 Reduced 2.76%	19,071 $4.11 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $572,278 - $688,873	2,571 Added 15.09%	19,612 $5.07 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $907,827 - $1.02 Million	3,584 Added 26.63%	17,041 $4.38 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $123,036 - $142,172	447 Added 3.44%	13,457 $3.83 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $2.63 Million - $3 Million	-10,255 Reduced 44.08%	13,010 $3.62 Million
Q4 2022 Feb 02, 2023	SELL	$252.44 - $306.72 $11,612 - $14,109	-46 Reduced 0.2%	23,265 $6.44 Million
Q3 2022 Nov 04, 2022	SELL	$194.69 - $268.46 $285,026 - $393,025	-1,464 Reduced 5.91%	23,311 $6.22 Million
Q2 2022 Aug 01, 2022	SELL	$187.54 - $223.02 $656,202 - $780,346	-3,499 Reduced 12.38%	24,775 $5.05 Million
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $1.03 Million - $1.3 Million	-5,332 Reduced 15.87%	28,274 $5.96 Million
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $1.1 Million - $1.41 Million	-4,905 Reduced 12.74%	33,606 $8.06 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $137,250 - $178,989	-485 Reduced 1.24%	38,511 $10.9 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $411,033 - $658,144	-1,587 Reduced 3.91%	38,996 $13.5 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $352,277 - $412,713	-1,450 Reduced 3.45%	40,583 $11.4 Million
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $541,271 - $814,748	2,291 Added 5.76%	42,033 $10.3 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $1.75 Million - $2.02 Million	-6,600 Reduced 14.24%	39,742 $11.3 Million
Q2 2020 Aug 03, 2020	BUY	$258.66 - $342.55 $389,800 - $516,222	1,507 Added 3.36%	46,342 $12.4 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $4.19 Million - $5.31 Million	-15,580 Reduced 25.79%	44,835 $14.2 Million
Q4 2019 Feb 18, 2020	BUY	$220.06 - $304.07 $1.11 Million - $1.53 Million	5,040 Added 9.1%	60,415 $17.9 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $1.33 Million - $1.49 Million	-6,128 Reduced 9.96%	55,375 $12.9 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $1.26 Million - $1.39 Million	-5,741 Reduced 8.54%	61,503 $14.4 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $121,791 - $190,495	-562 Reduced 0.83%	67,244 $15.9 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $4.65 Million - $5.89 Million	-16,709 Reduced 19.77%	67,806 $20.4 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.08 Million - $1.42 Million	3,694 Added 4.57%	84,515 $29.9 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $1.13 Million - $1.35 Million	-4,403 Reduced 5.17%	80,821 $23.5 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $1.71 Million - $2.41 Million	-6,561 Reduced 7.15%	85,224 $23.3 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $3.07 Million - $3.44 Million	-9,971 Reduced 9.8%	91,785 $29.2 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $1.68 Million - $1.97 Million	5,967 Added 6.23%	101,756 $31.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	95,789	95,789 $26 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Biogen Inc. Transaction History